Press Releases Press Releases Year: - Any -201820172016201520142013 August 03, 2018 Summary ToggleMelinta Therapeutics Announces Vabomere™ (meropenem and vaborbactam) Granted New Technology Add-On Payment by CMS July 11, 2018 Summary ToggleMelinta Therapeutics to Report Second Quarter 2018 Financial Results on August 7, 2018 June 13, 2018 Summary ToggleMelinta Therapeutics to Present at the JMP Securities Life Sciences Conference May 31, 2018 Summary ToggleMelinta Therapeutics Demonstrates Breadth of Commercial and Clinical Programs with 20 Presentations at ASM Microbe 2018 May 29, 2018 Summary ToggleMelinta Therapeutics Announces Closing of Underwritten Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock May 24, 2018 Summary ToggleMelinta Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference May 23, 2018 Summary ToggleMelinta Therapeutics Announces Pricing of Public Offering of Common Stock May 21, 2018 Summary ToggleMelinta Therapeutics Announces Proposed Offering of Common Stock May 11, 2018 Summary ToggleMelinta Therapeutics Launches New Antibiotic Stewardship Program to Combat Growing Threat of Antimicrobial Resistance May 08, 2018 Summary ToggleMelinta Therapeutics Reports First Quarter 2018 Financial Results Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last
Press Releases Year: - Any -201820172016201520142013 August 03, 2018 Summary ToggleMelinta Therapeutics Announces Vabomere™ (meropenem and vaborbactam) Granted New Technology Add-On Payment by CMS July 11, 2018 Summary ToggleMelinta Therapeutics to Report Second Quarter 2018 Financial Results on August 7, 2018 June 13, 2018 Summary ToggleMelinta Therapeutics to Present at the JMP Securities Life Sciences Conference May 31, 2018 Summary ToggleMelinta Therapeutics Demonstrates Breadth of Commercial and Clinical Programs with 20 Presentations at ASM Microbe 2018 May 29, 2018 Summary ToggleMelinta Therapeutics Announces Closing of Underwritten Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock May 24, 2018 Summary ToggleMelinta Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference May 23, 2018 Summary ToggleMelinta Therapeutics Announces Pricing of Public Offering of Common Stock May 21, 2018 Summary ToggleMelinta Therapeutics Announces Proposed Offering of Common Stock May 11, 2018 Summary ToggleMelinta Therapeutics Launches New Antibiotic Stewardship Program to Combat Growing Threat of Antimicrobial Resistance May 08, 2018 Summary ToggleMelinta Therapeutics Reports First Quarter 2018 Financial Results Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last
